BamSEC and AlphaSense Join Forces
Learn More

Intra-Cellular Therapies Inc.

NASDAQ: ITCI    
Share price (1/8/25): $82.56    
Market cap (1/8/25): $8.753 billion

Indentures Filter

EX-4.11
from S-3ASR 43 pages Intra-Cellular Therapies, Inc. Issuer and [ ] Trustee Indenture Dated as of [ ] Subordinated Debt Securities
12/34/56
EX-4.10
from S-3ASR 41 pages Intra-Cellular Therapies, Inc. Issuer and [ ] Trustee Indenture Dated as of [ ] Senior Debt Securities
12/34/56
EX-4.2
from 10-K 2 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended
12/34/56
EX-4.2
from 10-K 3 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended
12/34/56
EX-4.2
from 10-K 3 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended
12/34/56
EX-4.11
from S-3ASR 43 pages Intra-Cellular Therapies, Inc. Issuer and [ ] Trustee Indenture Dated as of [ ] Subordinated Debt Securities
12/34/56
EX-4.10
from S-3ASR 41 pages Intra-Cellular Therapies, Inc. Issuer and [ ] Trustee Indenture Dated as of [ ] Senior Debt Securities
12/34/56
EX-4.11
from S-3 43 pages Intra-Cellular Therapies, Inc. Issuer and [ ] Trustee Indenture Dated as of [ ] Subordinated Debt Securities
12/34/56
EX-4.10
from S-3 41 pages Intra-Cellular Therapies, Inc. Issuer and [ ] Trustee Indenture Dated as of [ ] Senior Debt Securities
12/34/56
EX-4.12
from S-3 43 pages Intra-Cellular Therapies, Inc. Issuer and [ ] Trustee Indenture Dated as of [ ] Subordinated Debt Securities
12/34/56
EX-4.11
from S-3 41 pages Intra-Cellular Therapies, Inc. Issuer and [ ] Trustee Indenture Dated as of [ ] Senior Debt Securities
12/34/56
EX-4.12
from S-3 43 pages Intra-Cellular Therapies, Inc. Issuer and [ ] Trustee Indenture Dated as of [ ] Subordinated Debt Securities
12/34/56
EX-4.11
from S-3 41 pages Intra-Cellular Therapies, Inc. Issuer and [ ] Trustee Indenture Dated as of [ ] Senior Debt Securities
12/34/56
EX-4.12
from S-3 43 pages Intra-Cellular Therapies, Inc. Issuer and [ ] Trustee Indenture Dated as of [ ] Subordinated Debt Securities
12/34/56
EX-4.11
from S-3 41 pages Intra-Cellular Therapies, Inc. Issuer and [ ] Trustee Indenture Dated as of [ ] Senior Debt Securities
12/34/56
EX-4.2.2
from 8-K 3 pages Amendment of Intra-Cellular Therapies, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.2.1
from 8-K 9 pages Intra-Cellular Therapies, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 8-K 2 pages The Company Will Furnish Without Charge to Each Shareholder Who So Requests, a Summary of the Powers, Designations, Preferences and Relative, Participating, Optional or Other Special Rights of Each Class of Stock of the Company and the Qualifications, Limitations or Restrictions of Such Preferences and Rights, and the Variations in Rights, Preferences and Limitations Determined for Each Series, Which Are Fixed by the Certificate of Incorporation of the Company, as Amended, and the Resolutions of the Board of Directors of the Company, and the Authority of the Board of Directors to Determine Variations for Future Series. Such Request May Be Made to the Office of the Secretary of the Company or to the Transfer Agent. the Board of Directors May Require the Owner of a Lost or Destroyed Stock Certificate, or His Legal Representatives, to Give the Company a Bond to Indemnify It and Its Transfer Agents and Registrars Against Any Claim That May Be Made Against Them on Account of the Alleged Loss or Destruction of Any Such Certificate. the Following Abbreviations, When Used in the Inscription on the Face of This Certificate, Shall Be Construed as Though They Were Written Out in Full According to Applicable Laws or Regulations
12/34/56
EX-4.1
from 10-12G/A 3 pages Promissory Note Dated: October 15, 2012
12/34/56
EX-4.1
from 10-12G 3 pages Promissory Note Dated: , 2012
12/34/56